Riskpilot← Back to searchSign inGet full accessASKER ØYELEGESENTER AS
ASActiveOrg 981400739Knud Askers Vei 28B, 1383 AskerMedical specialists activities · NACE 8622Est. 20002 employees
Revenue 2024
NOK 3,3M
+5% vs 2023
EBITDA margin
27.8%
-24% vs 2023
Equity ratio
7.4%
Financial strength
Net profit 2024
NOK 718K
-24% vs 2023
| Revenue | NOK 3,3M | +5% |
| EBITDA | NOK 916K | -24% |
| Net profit | NOK 718K | -24% |
| Total assets | NOK 1,4M | +105% |
| Equity | NOK 102K | -60% |
| Employees | 2 | — |
Legal name
ASKER ØYELEGESENTER AS
Org number
981400739
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. januar 2000
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av legekontor, herunder investering i driftsmidler og verdipapirer. Selskapet kan delta i andre selskaper.
Address
Knud Askers Vei 28B, 1383 Asker
Phone
+4766785690
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 493 | 1 970 | 2 994 | 3 150 | 3 293 |
| Staff expenses | −719 | −679 | −794 | −839 | −1 119 |
| EBITDA | 833 | 445 | 1 309 | 1 202 | 916 |
| Depreciation & amort. | −7 | −10 | −14 | −14 | −14 |
| EBIT | 825 | 435 | 1 296 | 1 188 | 903 |
| Net financials | 4 | 2 | 4 | 16 | 19 |
| Profit before tax | 829 | 437 | 1 300 | 1 204 | 922 |
| Tax | 180 | 94 | 286 | 265 | 204 |
| Net profit | 649 | 342 | 1 014 | 939 | 718 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 062 | 662 | 1 562 | 666 | 1 369 |
| Equity | 795 | 147 | 161 | 254 | 102 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 268 | 515 | 1 402 | 413 | 1 267 |
| Total debt | 268 | 515 | 1 402 | 413 | 1 267 |
EBITDA margin
27.8%
This company
15.8%
Market median
+76% vs market
20202024
Equity ratio
7.4%
This company
38.2%
Market median
-81% vs market
20202024
Return on equity
706.2%
This company
18.4%
Market median
+3738% vs market
20202024
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20202024
Asset turnover
2.41×
This company
1.12×
Market median
+115% vs market
20202024
Debt / equity
12.46×
This company
0.62×
Market median
-1910% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SI Contact Person | Contact Person | 2025 |
NC Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
HH Deputy Member | Deputy Member | 2021 – 2022 |
MK Contact Person | Contact Person | 2003 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Øyelegeservice As
ASKER ØYELEGESENTER AS Board members of ASKER ØYELEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halvor Holtan | Deputy Member | 0 companies |
| Steinar Ilebekk Dahle | Contact Person | 0 companies |
| Nina Charlotte Bille Brahe Veiby | Chief Executive Officer | 0 companies |
| Marit Kilsti | Contact Person | 0 companies |
| Grunde Dalsøren | Chairman | 0 companies |
| Per Frode Davanger Sandboe | Board of Directors | 0 companies |
| Per Klyve | Chairman | 0 companies |